Black Pepper & Piperine: Bioavailability, Formulation & Research

This page is part of the AMLApure Ingredient Science Library. It is intended for holistic, integrative, and nutrition-focused healthcare professionals and scientifically interested consumers. Content is educational and does not constitute medical advice.

Black Pepper & Piperine: Bioavailability and Human Research

What Is Black Pepper?

Black pepper (Piper nigrum L.) is a flowering vine in the family Piperaceae, native to the Western Ghats of southern India and now cultivated across tropical regions worldwide, including Vietnam, Indonesia, Brazil, and Malaysia. It is one of the most widely traded spices in human history and has been a staple of culinary, traditional medicine, and trade cultures across South Asia, Southeast Asia, the Middle East, and Europe for more than two millennia.

The spice is produced from the dried fruit (peppercorn) of the plant. Black pepper is produced by harvesting the unripe green peppercorns and drying them, causing the outer layer to wrinkle and darken. White pepper is produced from the same fruit with the outer layer removed. Green pepper is the unripe fruit preserved without extensive drying.

Culinary Black Pepper vs. Concentrated Extracts

It is important to distinguish between black pepper as a culinary spice and the concentrated black pepper extracts used in nutritional supplement formulations:

  • Culinary black pepper (ground peppercorns): the whole dried peppercorn in its minimally processed form; consumed as a food flavoring in gram-range amounts; contains piperine and other alkaloids alongside essential oils and other phytochemicals at naturally occurring concentrations
  • Black pepper extract: a concentrated preparation produced by extracting specific phytochemical fractions from the peppercorn; may be standardized to a defined percentage of piperine; used in supplement formulations in milligram-range amounts due to its higher concentration
  • Standardized piperine: a further concentrated or purified preparation standardized to a specific piperine content, such as 95% or higher piperine; the form most commonly used in pharmacokinetic research and in defined-dose supplement applications

Research conducted with standardized piperine at defined milligram doses is not directly equivalent to the effects of consuming culinary black pepper as a food spice.

What Is Piperine?

Piperine (1-piperoyl piperidine) is the primary alkaloid responsible for the characteristic pungency and heat of black pepper. It is present in both black and white pepper and is one of the most extensively studied naturally occurring alkaloids in nutritional and pharmacokinetic research.

Piperine was first isolated from Piper nigrum in the early nineteenth century and has been the subject of considerable scientific research interest, particularly in relation to its effects on intestinal physiology, drug-metabolizing enzyme activity, and the pharmacokinetics of co-administered compounds.

Piperine Content and Preparation Forms

  • Ground black pepper: piperine content typically ranges from approximately 2–9% by weight depending on variety, origin, and processing; consumed as a food ingredient
  • Black pepper extract: concentrated preparations may contain 5–95% piperine or greater, depending on the extraction and purification process
  • Standardized black pepper extract: products standardized to a defined piperine percentage (commonly 95%) used in research and supplement applications to enable consistent dosing

The distinctions between these forms are important when evaluating scientific research, as pharmacokinetic studies typically use defined milligram doses of standardized piperine rather than culinary black pepper amounts.

Why Piperine Is Used in Supplement Formulation

Piperine has attracted significant interest in nutritional supplement formulation based on a body of research examining its potential influence on the bioavailability and pharmacokinetics of certain compounds when co-administered.

The scientific interest in piperine as a formulation component stems from its studied effects on intestinal transport mechanisms and on certain drug-metabolizing enzyme pathways. Research suggests that piperine may, under specific conditions and with specific compounds, influence how some substances are absorbed or metabolized in the body.

Critical framing: Piperine’s effects on pharmacokinetics are compound-specific, dose-dependent, and formulation-dependent. Research demonstrating altered pharmacokinetics with one compound at a specific piperine dose does not establish that piperine universally enhances absorption of all nutrients, all botanical ingredients, or all supplements. This distinction is important both for accurate interpretation of the science and for honest formulation communication.

Piperine is included in some AMLApure formulations as a formulation component — not as a claim that it has been clinically proven to increase the bioavailability of every co-formulated ingredient.

How Piperine May Affect Bioavailability

Research has proposed several mechanisms through which piperine may influence the pharmacokinetics of co-administered compounds. The following reflects the current state of mechanistic and research evidence.

Intestinal Epithelial Transport

Laboratory and animal research has examined piperine’s effects on intestinal epithelial permeability and transporter activity. Some studies suggest piperine may transiently influence intestinal epithelial structure or function, potentially affecting the absorption of some compounds across the intestinal barrier. The significance of these effects in humans at supplement doses requires careful evaluation on a per-compound basis.

CYP Enzyme and P-glycoprotein Inhibition

Piperine has been studied for its effects on cytochrome P450 (CYP) enzymes — particularly CYP3A4 and CYP1A2 — and on P-glycoprotein (P-gp), an efflux transporter expressed in the intestine and other tissues. These enzymes and transporters play important roles in the first-pass metabolism and elimination of a wide range of endogenous compounds and exogenous substances including many pharmaceutical medications.

Inhibiting CYP3A4 or P-gp activity can increase the systemic exposure (AUC) of compounds that are substrates of these pathways — a mechanism that has attracted interest for increasing the bioavailability of certain nutritional compounds but that also constitutes the basis for piperine’s potential to alter medication exposure.

Important distinction: The same mechanisms that may increase bioavailability of some nutritional compounds may also alter the pharmacokinetics of medications that use the same metabolic pathways. These mechanisms are not selectively beneficial. This is the foundational reason why piperine-containing supplements warrant attention in the context of co-administered medications. See the Safety & Drug-Interaction Considerations section below.

Thermogenesis and Absorption Enhancement

Some research has proposed thermogenic or indirect effects of piperine on absorption processes. These mechanisms are less well-characterized in human research and should be considered preliminary relative to the CYP/P-gp mechanism data.

Evidence grade note: Much of the detailed mechanistic research on piperine has been conducted in vitro (cell culture) or in animal models. Human pharmacokinetic studies exist but are often small, conducted with specific compounds and specific piperine doses, and may not generalize broadly.

What Human Research Shows

Piperine has a meaningful human pharmacokinetic research base, with particular focus on its co-administration with specific compounds. The following summarizes key areas of human evidence.

Piperine and Curcumin (Curcuma longa)

The most frequently cited human pharmacokinetic study in the piperine literature is a 1998 study by Shoba et al. (Planta Medica) examining the co-administration of curcumin with piperine (20mg) in human subjects. The study reported a substantial increase in serum curcumin AUC compared to curcumin alone. This finding has been highly influential in supplement formulation contexts. However, it is important to note that this study used 20mg of piperine alongside 2g of curcumin, and the findings are specific to curcumin/piperine co-administration at those doses. They do not establish that piperine produces equivalent bioavailability enhancement for other compounds.

Piperine and Resveratrol

Some human and animal pharmacokinetic research has examined piperine co-administration with resveratrol, a polyphenol with low native bioavailability. Some studies report increased resveratrol AUC with piperine co-administration. As with curcumin research, compound-specificity and dose-specificity apply.

Piperine and Coenzyme Q10

A small number of studies have examined piperine and CoQ10 pharmacokinetics. Evidence is limited and research is less consistent than the curcumin literature.

Piperine and Pharmaceutical Compounds

A notable body of pharmacokinetic research has examined piperine’s effects on medications including propranolol, phenytoin, rifampicin, and other CYP/P-gp substrate drugs. Multiple studies have demonstrated measurable effects on drug pharmacokinetics with piperine co-administration — reinforcing the drug-interaction considerations discussed in the Safety section.

Honest Summary

Human evidence supports the conclusion that piperine can influence the pharmacokinetics of specific compounds under specific conditions. The best-replicated finding involves curcumin co-administration. Evidence for broader, generalized bioavailability enhancement across diverse nutritional compounds is limited and should not be assumed. The same pharmacokinetic mechanisms that may increase the bioavailability of some nutritional compounds have also been demonstrated to alter exposure to medications — a consideration that must be taken seriously.

Authoritative external resources: PubMed — piperine bioavailability human research | Cochrane Library

Piperine in AMLApure Formulations

Piperine (as black pepper extract) is included as a formulation component across several AMLApure product families. Its inclusion reflects the research background on piperine as a formulation ingredient in botanical supplement contexts.

Products That Contain Piperine

Piperine / black pepper extract is currently included in the following AMLApure product families:

  • AMLA formulation(s)
  • All current Enterinex formulations
  • All current Nattokinase formulations

For the exact ingredient form, standardization, and amount of piperine or black pepper extract used in each formulation, please refer to the current Supplement Facts panel on the individual product page. AMLApure does not assert on this page that piperine has been clinically proven to increase the absorption of every co-formulated ingredient in these products, nor does it claim proven synergistic outcomes from specific ingredient combinations unless supported by research on those exact combinations.

Products That Do NOT Contain Piperine

Piperine and black pepper extract are not included in:

  • Glycanda™ Metabolic GLP-1 Support
  • AMLApure Omega-3 Oil

For AMLApure’s broader formulation philosophy and ingredient standards, see The AMLApure Ingredient & Quality Pledge.

Black Pepper vs. Standardized Piperine

Understanding the distinctions among different black pepper preparations is important for accurately interpreting research and supplement labeling.

Culinary Black Pepper

Ground black pepper used as a food spice contains piperine at naturally occurring concentrations (typically 2–9% by weight), alongside essential oils, other alkaloids, and phytochemicals. At culinary food amounts, black pepper’s contribution of piperine is in a very different range from the milligram-level doses used in pharmacokinetic research. Research findings from defined piperine dose studies are not equivalent to adding extra black pepper to food.

Black Pepper Powder (Supplement Grade)

Milled black pepper in supplement capsule or powder form provides the full peppercorn matrix at higher doses than typical culinary use, but without concentration or standardization of the piperine fraction. Piperine content per serving varies with variety and processing.

Black Pepper Extract

Concentrated extracts produced by extracting the piperine fraction from the peppercorn. May be standardized to a defined piperine percentage (e.g., 5%, 20%, 50%, 95%). Widely used in nutritional supplement formulations where a defined piperine contribution per serving is required for formulation consistency.

Why This Distinction Matters for Research Interpretation

The majority of human pharmacokinetic research on piperine uses standardized piperine preparations at defined milligram doses (commonly 5–20mg). When evaluating whether a supplement product’s piperine component is likely to produce effects similar to those observed in research, the exact form, standardization percentage, and per-serving piperine amount are all relevant. A product listing “black pepper extract” without specifying the standardization percentage and serving amount does not allow precise comparison to published research.

Quality & Standardization

Botanical Identity

Piper nigrum L. is the accepted species for black pepper. Ingredient identity should be confirmed by appropriate methods including macroscopic, microscopic, chromatographic (HPLC), or DNA-based verification. Multiple Piper species exist; P. longum (long pepper) is a related species with different alkaloid composition and is not equivalent to P. nigrum.

Extraction and Concentration

Black pepper extracts are commonly produced using solvent extraction (ethanol, methanol) or CO2-based extraction methods. The extraction method influences the resulting phytochemical profile and piperine concentration. Highly concentrated piperine preparations (90–95%+) may use additional purification steps beyond standard extraction.

Piperine Standardization

Standardization specifies the minimum percentage of piperine per unit mass of extract, enabling consistent per-serving dosing. Common commercial standardizations include 95% piperine (typical for highly purified piperine ingredients) and lower concentrations (5–20%) in standard black pepper extracts. The standardization percentage and the serving amount together determine the actual piperine dose per serving.

Third-Party Testing

Quality botanical ingredient sourcing includes testing for botanical identity, purity (heavy metals, pesticide residues, microbial contaminants), and piperine content. Third-party laboratory certificates of analysis are standard quality assurance expectations for responsibly sourced supplement ingredients.

Formulation Consistency

Because piperine’s pharmacokinetic effects are dose-dependent, consistent piperine delivery per serving requires a standardized ingredient at a defined specification. Variability in piperine content across batches would produce variability in the delivered piperine dose.

Safety & Drug-Interaction Considerations

This section addresses an important safety topic. Please read carefully if you take prescription medications or manage medical conditions.

Piperine and Drug-Metabolizing Pathways

Piperine has been researched for its effects on cytochrome P450 enzymes (particularly CYP3A4 and CYP1A2) and P-glycoprotein (P-gp) — metabolic and transport systems that play central roles in the absorption, distribution, and elimination of many pharmaceutical medications as well as endogenous compounds.

Inhibition of these pathways by piperine has been demonstrated in laboratory models and in some human pharmacokinetic studies. When these pathways are inhibited, the plasma concentration and systemic exposure of co-administered substances that rely on these pathways for clearance may increase. Depending on the medication, increased systemic exposure could alter its therapeutic effects or side effect profile.

Who Should Be Most Attentive to This

Individuals taking the following categories of medications should discuss the use of concentrated piperine-containing supplements with their prescribing physician or pharmacist before use:

  • Immunosuppressant medications (e.g., cyclosporine, tacrolimus) — many are CYP3A4/P-gp substrates with narrow therapeutic windows
  • Anticoagulant medications (e.g., warfarin) — which require careful monitoring of drug levels
  • Anticonvulsant medications (e.g., phenytoin) — human pharmacokinetic studies have examined piperine interactions with this drug class
  • Cardiovascular medications including some antihypertensives and antiarrhythmics that are CYP3A4 substrates
  • HIV antiretroviral medications — many are CYP3A4/P-gp substrates
  • Any medication with a narrow therapeutic index where small changes in drug exposure could be clinically meaningful

This list is illustrative, not exhaustive. A pharmacist is the best resource for evaluating whether a specific medication has CYP3A4, CYP1A2, or P-gp substrate characteristics that would make piperine co-administration a concern.

Context and Dose Dependency

The significance of piperine’s effects on drug-metabolizing pathways is dose-dependent and context-dependent. The piperine amounts present in culinary black pepper as a food spice are substantially lower than those used in pharmacokinetic research studies or delivered by concentrated supplement preparations. However, individuals on sensitive medications should not assume that low-dose piperine is without risk without consulting their healthcare provider.

Important Guidance

Never modify, reduce, or discontinue prescribed medication in favor of a dietary supplement without explicit guidance from your prescribing physician.

If you take prescription medications and are considering supplements containing concentrated piperine or black pepper extract, discuss this with your physician or pharmacist before beginning supplementation.

This educational content is not a substitute for professional medical or pharmacological advice.

Frequently Asked Questions

What is piperine?

Piperine is the primary alkaloid in black pepper (Piper nigrum) and is responsible for the characteristic pungency and heat of black and white pepper. It is one of the most extensively studied naturally occurring alkaloids in nutritional and pharmacokinetic research, particularly in relation to its effects on the bioavailability of certain co-administered compounds and on drug-metabolizing enzyme pathways.

Is piperine the same as black pepper?

No. Piperine is a specific alkaloid compound found within black pepper. Black pepper is the whole spice — the dried fruit of Piper nigrum — which contains piperine alongside essential oils, other alkaloids, and a range of other phytochemicals. Standardized piperine or black pepper extract used in nutritional supplements is a concentrated preparation with a defined piperine content, distinct from culinary black pepper.

What is Piper nigrum?

Piper nigrum L. is the accepted scientific binomial name for black pepper, identifying it within the genus Piper and the family Piperaceae. It is the species that produces the peppercorns used as the culinary spice and the source material for black pepper extract and standardized piperine supplements. It is botanically distinct from long pepper (Piper longum) and other Piper species.

Why is piperine used in supplements?

Piperine is used as a formulation component in some nutritional supplements based on research examining its potential to influence the pharmacokinetics of certain co-administered compounds. Research suggests that piperine may, under specific conditions and with specific compounds, affect intestinal transport and drug-metabolizing enzyme activity in ways that can alter the absorption or metabolism of some co-administered substances. These effects are compound-specific and dose-dependent.

Does piperine increase nutrient absorption?

Piperine has been studied for its effects on the pharmacokinetics of specific compounds. The most well-characterized human evidence involves curcumin, where a 1998 study (Shoba et al.) reported substantially increased serum curcumin levels with piperine co-administration at specific doses. Evidence exists for some other compounds. However, piperine’s effects are compound-specific, dose-specific, and formulation-specific. They cannot be generalized to all nutrients or supplements without evidence for each specific compound.

Does piperine increase absorption of every supplement?

No. This is an important distinction. Piperine’s effects on pharmacokinetics have been studied for specific compounds and are not established as a universal mechanism that reliably increases the absorption of every supplement or nutritional ingredient with which it is co-formulated. Claims that piperine universally boosts absorption of all nutrients are not supported by the current scientific evidence base.

What is standardized black pepper extract?

Standardized black pepper extract is a concentrated preparation from Piper nigrum that specifies a minimum percentage of piperine per unit mass (e.g., 95% piperine). Standardization ensures consistent piperine content per serving, enabling more reliable dosing compared to non-standardized black pepper powder. The most widely used commercial standardized piperine ingredient is BioPerine®, a registered trademark product standardized to 95% piperine, though other standardized black pepper extracts are also used in the supplement industry.

Which AMLApure products contain piperine?

Piperine (as black pepper extract) is included in AMLApure’s AMLA formulation(s), all current Enterinex formulations, and all current Nattokinase formulations. For the exact ingredient form, standardization, and amount, refer to the Supplement Facts panel on the individual product page.

Does Glycanda contain piperine?

No. Piperine and black pepper extract are not included in the Glycanda™ Metabolic GLP-1 Support formula. Glycanda™ is formulated without piperine as part of its botanical and prebiotic fiber ingredient profile.

Does AMLApure Omega-3 Oil contain piperine?

No. AMLApure Omega-3 Oil does not contain piperine or black pepper extract.

Can piperine interact with medications?

Yes — this is an important consideration. Piperine has been shown to influence cytochrome P450 enzymes (particularly CYP3A4 and CYP1A2) and P-glycoprotein, which are involved in the metabolism and elimination of many pharmaceutical medications. Inhibiting these pathways may increase the plasma concentration and systemic exposure of medications that rely on them for clearance. Individuals taking prescription medications — particularly those with narrow therapeutic windows such as immunosuppressants, anticoagulants, anticonvulsants, and certain cardiovascular or antiretroviral medications — should discuss the use of piperine-containing supplements with their physician or pharmacist before beginning supplementation.

References & Further Reading

  • Shoba G, et al. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 1998;64(4):353–356. PubMed
  • Bhardwaj RK, et al. Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4. J Pharmacol Exp Ther. 2002;302(2):645–650. PubMed
  • Bano G, et al. Effect of piperine on bioavailability and pharmacokinetics of propranolol and theophylline in healthy volunteers. Eur J Clin Pharmacol. 1991;41(6):615–617. PubMed
  • Pattanaik S, et al. Effect of piperine on the steady-state pharmacokinetics of phenytoin in patients with epilepsy. Phytother Res. 2009;23(8):1144–1148. PubMed
  • Kesarwani K, Gupta R. Bioavailability enhancers of herbal origin: an overview. Asian Pac J Trop Biomed. 2013;3(4):253–266. PubMed
  • Meghwal M, Goswami TK. Piper nigrum and piperine: an update. Phytother Res. 2013;27(8):1121–1130. PubMed
  • PubMed: Piperine bioavailability human research
  • NIH National Center for Complementary and Integrative Health (NCCIH): nccih.nih.gov

This page is part of the AMLApure Ingredient Science Library. Content is educational and does not constitute medical advice. These statements have not been evaluated by the FDA. AMLApure products are not intended to diagnose, treat, cure, or prevent any disease.